The Predictive Value of the Fibrinogen–Albumin-Ratio Index on Surgical Outcomes in Patients with Advanced High-Grade Serous Ovarian Cancer
The FARI appears to act as a surrogate for higher intra-abdominal tumor load. After clinical validation, FARI could serve as a readily available serologic biomarker to complement preoperative patient assessment, helping to identify patients who are likely to achieve complete tumor resection during primary cytoreductive surgery.
Authors
- Stefanie Aust (ORCID: https://orcid.org/0000-0002-6760-949X)
- Nicole Concin (ORCID: https://orcid.org/0000-0002-9795-2643)
- Melina Danisch (ORCID: https://orcid.org/0009-0003-0289-3738)
- Stephan Polterauer (ORCID: https://orcid.org/0000-0002-9649-4505)
- Paul Kofler (ORCID: https://orcid.org/0000-0001-7139-1481)
- Patrik Petrov (ORCID: https://orcid.org/0009-0005-9980-5312)
- Magdalena Postl (ORCID: https://orcid.org/0000-0001-7570-0907)
- Thomas Bartl (ORCID: https://orcid.org/0000-0002-1938-1574)
- Fridolin Schrott
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- Cancers
- Published
- 2024-09-27
- DOI
- https://doi.org/10.3390/cancers16193295
- Citations
- 5
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- Universität Wien
- Medizinische Universität Wien